Mirza Dilić
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mirza Dilić has a total of 211 co-authors. Here are the top co-authors by number of shared publications:
- Alden Begić
Klinički centar Univerziteta Sarajevo, Bolnička 25, 71000 Sara-jevo, Bosnia and Herzegovina
4 shared publications - Amina Bičo3 shared publications
- Dževdet Radončić2 shared publications
- Agnieszka Adamska
School of Medicine and National Institute for Prevention and Cardiovascular Health, University of Galway , Galway
1 shared publication Agnieszka Wsol
1 shared publicationAlden Begic
1 shared publication
Latest Publications
- 29 August 2026
- Published by Oxford University Press (OUP) in European Heart Journal
European Society of Cardiology guidelines on prevention and rehabilitation in coronary heart disease and current practice: the EUROASPIRE VI survey
Background and Aims: We investigated whether patients with coronary heart disease (CHD) in Europe are achieving the standards set by prevention and rehabilitation guidelines. Variability in achieved standards was also studied: (i) between countries, (ii) between geographical risk regions, and (iii) according to attendance at cardiac rehabilitation (CR). Methods: EUROASPIRE VI is an observational study conducted between September 2024 and February 2026 in 160 hospitals across 27 countries. Geographical risk regions were defined as high, moderate, or low based on World Health Organization cardiovascular mortality data. Results were standardized by age and sex. Results: Among 8590 patients with CHD (23.7% female), 17.1% were current smokers, 32.0% were obese, and 33.5% reported low physical activity. 59.8% were above blood pressure target (systolic ≥130 and/or diastolic ≥80 mmHg), 82.7% were above LDL-cholesterol target (≥1.4 mmol/L), 32.8% had known diabetes of whom 42.2% had HbA1c ≥7%, and 30.6% had chronic kidney disease. Prevalences of these risk factors were all highest in countries from high-risk regions. 29.1% of patients attended at least one CR session, with country variability ranging from 0% to 79% and differing by risk region (55.9% low risk, 29.7% moderate risk and 10.2% high risk; P < .001). Attendance at CR programmes was associated with significantly better lifestyles, risk factor control, and use of cardioprotective drugs. Conclusions: Most European patients are not achieving targets set by prevention guidelines. Despite better outcomes for those attending CR, there is marked variability in CR attendance and evidence of inverse care, with lowest attendance in highest risk regions. These results provide a baseline to inform the challenges for future implementation of the first European Society of Cardiology guideline on CR.
- 29 August 2026
- Published by Oxford University Press (OUP) in European Heart Journal
European Society of Cardiology guidelines on prevention and rehabilitation in coronary heart disease and current practice: the EUROASPIRE VI survey
Background and Aims: We investigated whether patients with coronary heart disease (CHD) in Europe are achieving the standards set by prevention and rehabilitation guidelines. Variability in achieved standards was also studied: (i) between countries, (ii) between geographical risk regions, and (iii) according to attendance at cardiac rehabilitation (CR). Methods: EUROASPIRE VI is an observational study conducted between September 2024 and February 2026 in 160 hospitals across 27 countries. Geographical risk regions were defined as high, moderate, or low based on World Health Organization cardiovascular mortality data. Results were standardized by age and sex. Results: Among 8590 patients with CHD (23.7% female), 17.1% were current smokers, 32.0% were obese, and 33.5% reported low physical activity. 59.8% were above blood pressure target (systolic ≥130 and/or diastolic ≥80 mmHg), 82.7% were above LDL-cholesterol target (≥1.4 mmol/L), 32.8% had known diabetes of whom 42.2% had HbA1c ≥7%, and 30.6% had chronic kidney disease. Prevalences of these risk factors were all highest in countries from high-risk regions. 29.1% of patients attended at least one CR session, with country variability ranging from 0% to 79% and differing by risk region (55.9% low risk, 29.7% moderate risk and 10.2% high risk; P < .001). Attendance at CR programmes was associated with significantly better lifestyles, risk factor control, and use of cardioprotective drugs. Conclusions: Most European patients are not achieving targets set by prevention guidelines. Despite better outcomes for those attending CR, there is marked variability in CR attendance and evidence of inverse care, with lowest attendance in highest risk regions. These results provide a baseline to inform the challenges for future implementation of the first European Society of Cardiology guideline on CR.
- 1 November 2022
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 17 (9-10) , 166
Modifiable risk factors for heart disease and coronary flow reserve assessed by transthoracic echocardiography
- 1 November 2022
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 17 (9-10) , 166
Modifiable risk factors for heart disease and coronary flow reserve assessed by transthoracic echocardiography
- 1 November 2018
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 13 (11-12) , 444
Carotid endarterectomy versus carotid artery stenting: what is really the standard of care?
- 1 November 2018
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 13 (11-12) , 444
Carotid endarterectomy versus carotid artery stenting: what is really the standard of care?
- 1 November 2018
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 13 (11-12) , 443
Peak-systolic velocity as independent risk factor for carotid artery stenosis?
- 1 November 2018
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 13 (11-12) , 443
Peak-systolic velocity as independent risk factor for carotid artery stenosis?
- 1 November 2018
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 13 (11-12) , 440
Postprocedural dual anticoagulant and antiplatelet treatment after peripheral artery disease endovascular interventions: a shifting paradigm
- 1 November 2018
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 13 (11-12) , 440
Postprocedural dual anticoagulant and antiplatelet treatment after peripheral artery disease endovascular interventions: a shifting paradigm
- 1 October 2017
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 12 (9-10) , 353
Difference in biomarker profiles in heart failure with reduced and preserved ejection fraction
- 1 October 2017
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 12 (9-10) , 353
Difference in biomarker profiles in heart failure with reduced and preserved ejection fraction